Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
22/05/2023 21:47
May 22 (Reuters) - Ironwood Pharmaceuticals Inc
IRWD.O :
* IRONWOOD PHARMACEUTICALS: IF DEAL TERMINATED IN SOME
CASES,
VECTIVBIO WILL BE REQUIRED TO PAY CO TERMINATION FEE OF $23.7
MILLION - SEC FILING
* IRONWOOD PHARMACEUTICALS: IF DEAL TERMINATED IN SOME
CASES, CO
WILL BE REQUIRED TO PAY VECTIVBIO REVERSE TERMINATION FEE OF
$59.2 MILLION - SEC FILING
Further company coverage: IRWD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation